Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126819661 | 12681966 | 1 | I | 20160718 | 20160817 | 20160824 | 20160824 | EXP | CA-009507513-1608CAN010934 | MERCK | 57.42 | YR | F | Y | 0.00000 | 20160824 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126819661 | 12681966 | 1 | PS | EMEND | APREPITANT | 1 | Oral | 125 MG, ONCE (STRENGTH 125MG) | 21549 | 125 | MG | CAPSULE | 1X | ||||||
| 126819661 | 12681966 | 2 | SS | EMEND | APREPITANT | 1 | Oral | 80 MG, DAY2 AND DAY 3 (STRENGTH 80MG) | 21549 | 80 | MG | CAPSULE | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126819661 | 12681966 | 1 | Prophylaxis of nausea and vomiting |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126819661 | 12681966 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126819661 | 12681966 | Asthenia | |
| 126819661 | 12681966 | Fatigue | |
| 126819661 | 12681966 | Peripheral swelling |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126819661 | 12681966 | 1 | 20160718 | 20160718 | 0 | |
| 126819661 | 12681966 | 2 | 20160719 | 0 |